Strides Pharma’s JV gets USFDA’s approval for Albendazole Tablets

11 Dec 2018 Evaluate

Strides Pharma Science’s Joint Venture (JV) -- Strides Vivimed Pte., Singapore has received approval for Albendazole Tablets USP 200 mg from the United States Food & Drug Administration (USFDA). This is the second generic approval by US FDA for Albendazole Tablets.

Albendazole Tablets is a generic version of Albenza Tablets of Amneal Pharmaceuticals, Inc. According to IQVIA MAT data, the US market for Albendazole Tablets USP 200 mg is approximately $100 million.

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.

Strides Pharma Scien Share Price

793.35 -15.60 (-1.93%)
30-Jan-2026 09:23 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1591.45
Dr. Reddys Lab 1212.35
Cipla 1320.40
Zydus Lifesciences 889.95
Lupin 2152.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×